ARTICLE | Clinical News
Interleukin-11: Began Phase III trial in 250 patients
November 13, 1995 8:00 AM UTC
Genetics Institute Inc. (GENIZ), Cambridge, Mass. Product: Interleukin-11 Indication: Restore platelet count after chemotherapy Status: Began Phase III trial in 250 patients ...